2 No-Brainer Dividend Stocks to Buy for the New Year
As you build your portfolio through the years, you may find that you gravitate toward stocks across an assortment of sectors, with a range of risk profiles, growth stories, and businesses. Diversifying your portfolio is a wise move in any environment, as you can enjoy the fruits of companies with varying degrees of growth that perform differently amid market highs and lows.
Dividend stocks can be one such excellent type of investment to help you boost your returns and give you extra capital to reinvest or make use of as you so choose. If you're hunting for two great Dividend stocks to buy for 2024 and hold for the long term, here are two no-brainer names to consider for your portfolio.
AbbVie (NYSE: ABBV) has 52 years of consecutive dividend increases under its belt, thanks to the storied dividend history of its parent company, Abbott Laboratories. Since the company was spun off from Abbott at the start of 2013, it has grown its payouts by a whopping 290%. At today's share price, its yield is around 4%, and the stock has delivered a 130% total return over the past five years.
Source Fool.com
Abbott Laboratories Stock
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Abbott Laboratories.
As a result the target price of 116 € shows a positive potential of 23.13% compared to the current price of 94.21 € for Abbott Laboratories.
